Log In
Print this Print this

Hep-Lido-A (URG101)

Also known as: HLA (formerly U101)

  Manage Alerts
Collapse Summary General Information
Company Urigen Pharmaceuticals Inc.
DescriptionIntravesical formulation of heparin and alkalinized lidocaine
Molecular Target Sodium channel
Mechanism of ActionNa channel blocker
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationCystitis
Indication DetailsTreat interstitial cystitis (IC); Treat painful bladder syndrome (PBS) and interstitial cystitis (IC)
Regulatory Designation
PartnerImprimis Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
Get a free BioCentury trial today